Hydrogen Sulfide Signaling in the Tumor Microenvironment: Implications in Cancer Progression and Therapy

Author(s)

Machado-Neto, Joao Agostinho ; Cerqueira, Anderson Romerio Azevedo ; Verissimo-Filho, Sidney ; Muscara, Marcelo Nicolas ; Costa, Soraia Katia Pereira ; Lopes, Lucia Rossetti

• Document type: Journal article
• Source: Antioxidants & Redox Signaling; v. 40, n. 4-6, p. 22-pg., 2023-09-22.

Abstract

Significance: Cancer is a complex and heterotypic structure with a spatial organization that contributes to challenges in therapeutics. Enzymes associated with producing the gasotransmitter hydrogen sulfide (H2S) are differentially expressed in tumors. Indeed, critical and paradoxical roles have been attributed to H2S in cancer-promoting characteristics by targeting both cancer cells and their milieu. This review focuses on the evidence and knowledge gaps of H2S on the tumor redox microenvironment and the pharmacological effects of H2S donors on cancer biology.Recent Advances: Endogenous and pharmacological concentrations of H2S evoke different effects on the same cell type: physiological H2S concentrations have been associated with tumor development and progression. In contrast, pharmacological concentrations have been associated with anticancer effects.Critical Issues: The exact threshold between the promotion and inhibition of tumorigenesis by H2S is largely unknown. The main issues covered in this review include H2S-modulated signaling pathways that are critical for cancer cells, the potential effects of H2S on cellular components of the tumor microenvironment, temporal modulation of H2S in promoting or inhibiting tumor progression (similar to observed for inflammation), and pharmacological agents that modulate H2S and which could play a role in antineoplastic therapy.Future Directions: Given the complexity and heterogeneity of tumor composition, mechanistic studies on context-dependent pharmacological effects of H2S donors for cancer therapy are necessary. These studies must determine the critical signaling pathways and the cellular components involved to allow advances in the rational use of H2S donors as antineoplastic agents. (AU)

• FAPESP's process: 20/12432-6 - Investigating the redox mechanisms of Vemurafenib resistance in Melanoma cells
• Grantee: Lucia Rossetti Lopes
• Support Opportunities: Regular Research Grants
• FAPESP's process: 16/06146-5 - Bioavailability of Hydrogen Sulfide in a topical nanoformulation in experimental psoriasis
• Grantee: Soraia Katia Pereira Costa
• Support Opportunities: Regular Research Grants
• FAPESP's process: 19/23864-7 - Comprehensive analysis of genomic data for identification and validation of novel therapeutic targets involved in cellular cytoskeleton regulation in acute Leukemia
• Grantee: João Agostinho Machado Neto
• Support Opportunities: Regular Research Grants
• FAPESP's process: 13/07937-8 - Redoxome - Redox Processes in Biomedicine
• Grantee: Ohara Augusto
• Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC